Stockscreener 앱 받기
572.32
8.71%
45.86
시장 영업 전:
568.00
-4.32
-0.75%
전일 마감가:
$526.46
열려 있는:
$573.68
하루 거래량:
5.80M
Relative Volume:
2.46
시가총액:
$212.69B
수익:
$45.20B
순이익/손실:
$6.87B
주가수익비율:
31.47
EPS:
18.1888
순현금흐름:
$6.75B
1주 성능:
+5.36%
1개월 성능:
+21.94%
6개월 성능:
-8.57%
1년 성능:
+22.63%
1일 변동 폭
$568.84
$587.49
1주일 범위
$495.04
$587.49
52주 변동 폭
$435.27
$643.99
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
572.32 | 212.69B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
192.50 | 135.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
539.37 | 42.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
139.74 | 39.47B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
264.69 | 37.91B | 2.50B | -226.32M | 71.51M | -1.6412 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | DZ Bank | Buy |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-12-01 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades - Yahoo! Finance Canada
Thermo Fisher Scientific Q2 Earnings Call Highlights - Yahoo Finance
TMO Q2 FY2026 earnings call - finance.biggo.com
Is It Too Late to Buy Thermo Fisher Scientific Inc (TMO) After 8 - GuruFocus
Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $606.79, Implies 15% Upside - TradingView
Thermo Fisher Scientific Inc.'s stock price skyrockets to $572.32, marking an impressive 8.71% surge - Smartkarma
Thermo Fisher Stock Jumps on Second Quarter Results - WFMZ.com
Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlig - GuruFocus
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific (TMO) Reports Strong Q2 2026 Earnings a - GuruFocus
Thermo Fisher Points to Improving End-Market ActivityThermo Fisher Scientific (NYSE:TMO) - Benzinga
Leerink Partners Adjusts Price Target on Thermo Fisher to $620 From $600, Maintains Outperform Rating - marketscreener.com
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $630 From $585, Maintains Buy Rating - marketscreener.com
Thermo Fisher TMO Stock Draws Bullish Calls Ahead Of Q2 - timothysykes.com
Thermo Fisher Scientific Reports Second Quarter 2026 Results - BioSpace
Thermo Fisher Scientific (NYSE:TMO) Gains Focus In A Selective Market - Kalkine Media
Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today - Yahoo Finance
Thermo Fisher Q2 revenue rises 10% to $11.99 billion - grafa.com
Thermo Fisher Stock Draws Bullish Targets Ahead Of Q2 - StocksToTrade
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 9.89% on Jul 23: A Full Analysis - TradingKey
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $615 From $570 - marketscreener.com
Thermo Fisher Stock Climbs As Analysts Hike Targets Ahead Q2 - timothysykes.com
TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market - The Globe and Mail
Thermo Fisher Rises as Instrument Demand Recovery Lifts Outlook - Bloomberg.com
Thermo Fisher (NYSE:TMO) shares gain as instrument margins exceed sales growth - TechStock²
Thermo Fisher raises annual profit forecast as customer demand improves - Reuters
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday - Benzinga
Thermo Fisher Scientific Stock Climbs As Analysts Ramp Up Bullish Calls - StocksToTrade
Why is Thermo Fisher Scientific stock surging today? - Investing.com
Earnings call transcript: Thermo Fisher tops Q2 2026 estimates and lifts outlook - Investing.com
Here's What Key Metrics Tell Us About Thermo Fisher (TMO) Q2 Earnings - Yahoo Finance
Thermo Fisher stock rebounds after Q2 beat (update) (TMO:NYSE) - Seeking Alpha
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 6, 2025. - marketscreener.com
Thermo Fisher beats second-quarter expectations as customer demand strengthens (NYSE:TMO) - Yahoo Finance
Thermo Fisher Scientific (TMO) Q2 2026 earnings summary - Quartr
Thermo Fisher Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026 - marketscreener.com
Thermo Fisher Scientific (TMO) Reports Strong Q2 Earnings with R - GuruFocus
Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Is Thermo Fisher Scientific Inc. (TMO) Undervalued After Q2 Earn - GuruFocus
Thermo Fisher Q2 EPS beats estimates on 10% sales growth - scanx.trade
Why is Thermo Fisher Scientific stock surging today? By Investing.com - Investing.com Canada
Pyridine & Pyridine Derivatives Market Size to Reach USD 1,255.74 Million by 2035 on Rising Agrochemical and Pharma Demand | SNS Insider - GlobeNewswire Inc.
Thermo Fisher stock rises 3% on second quarter earnings beat - Yahoo Finance
Thermo Fisher beats quarterly estimates as customer demand improves - marketscreener.com
Thermo Fisher Scientific's Fiscal Q2 Adjusted Earnings, Revenue Increase - marketscreener.com
Earnings Flash (TMO) Thermo Fisher Scientific Inc. Reports Q2 Revenue $11.99B, vs. FactSet Est of $11.71B - marketscreener.com
Earnings Flash (TMO) Thermo Fisher Scientific Inc. Posts Q2 Adjusted EPS $6.03 per Share, vs. FactSet Est of $5.72 - marketscreener.com
Thermo Fisher stock rises 3% on second quarter earnings beat By Investing.com - Investing.com South Africa
Thermo Fisher’s (NYSE:TMO) Q2 CY2026 Sales Top Estimates - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Earnings: 2Q Adjusted EPS Surpasses Estimates with Strong Revenue Growth - Smartkarma
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
7.46%
1.03%
자본화:
|
볼륨(24시간):